Clinical Trials Logo

Clinical Trial Summary

Type of study:Prospective, single-center, non-therapeutic, of routine care No randomization, no modifications of the usual care, study results are not available for the physicians in charge of the patient.

Objectives:

- The main objective of this study is to evaluate the ability of the thromboelastogram (ROTEM®) to detect clotting disorders related to pancreas-kidney transplantation, comparing ROTEM ® profiles during the perioperative period of two different types of transplantation (kidney alone and simultaneous pancreas-kidney)

- The secondary objectives are:

1. To assess the incidence and type of coagulation disorders during the perioperative period of these two types of transplantation

2. To study correlation values between thrombolelastogram and standard coagulation parameters

Population study:

- Evaluated group: 40 pancreas-kidney recipients

- Control group: 80 kidney recipients

- Recruitment periods: 24 months

- Patient Monitoring: 48 hours

- Total duration of the study: 36 months.

- Ethics: Study of routine care. Oral and written information given to patients. Validation of the study protocol by the local ethics committee (CPP Sud Est II: Protocol No. HCL / P 2012.727)


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Screening


Related Conditions & MeSH terms


NCT number NCT02385006
Study type Interventional
Source Hospices Civils de Lyon
Contact
Status Completed
Phase N/A
Start date February 2013
Completion date November 2014

See also
  Status Clinical Trial Phase
Completed NCT02594345 - Effect of Exosomes Derived From Red Blood Cell Units on Platelet Function and Blood Coagulation N/A
Completed NCT01422304 - Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038) Phase 3
Completed NCT00775398 - Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® on Coagulation Parameters. N/A
Completed NCT03535090 - Coagulation After Intravenous Methylprednisolone Administration
Recruiting NCT02745054 - Safety of Oral Anticoagulants Registry
Completed NCT01635361 - Understanding and Appraising the New Medicine Service in England N/A
Completed NCT01195025 - Volume Kinetics for Starch Solution and Acetated Ringers N/A
Completed NCT05365542 - Anticoagulation in Chronic Hemodialysis Patients Versus Hemodialyzer Fiber Patency, Bleedings and Quality of Life
Completed NCT02321917 - Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC) N/A
Completed NCT03203148 - Two Monitors for Measuring the Activated Clotting Time: A Comparison